Add this topic to your myFT Digest for news straight to your inbox
Divisions between richer and poorer nations threaten progress on talks as Lancet study shows scale of Covid toll
French government bill to propose giving some terminally ill the option to request ‘aid in dying’
A number of other countries have now legalised the practice
Breakthrough medicine will now be subject to further review by committee of independent experts
Drugmaker releases promising trial results for a pill and expects to enter China this year
Chief executive of aspirin-to-Roundup group has limited options to sort fallout of ill-fated Monsanto purchase
With the pandemic boom over, consumer medical start-ups now face fickle customers and a crowded market place
Avid Bioservices had an oopsie
There is still room for growth in Japan’s $53bn dispensing pharmacy market
The company’s deleveraging route looks long and distinctly uncertain
Bill Anderson quashes speculation after suspending break-up of indebted German drugs-to-pesticides group
Bill Anderson expects further profit declines at the aspirin-to-agriculture conglomerate in 2024
Nice fails to approve Enhertu due to value-for-money concerns despite it being recommended in Scotland
US group hunts for outsourcers to lift production of Zepbound as it takes on Danish group’s Wegovy blockbuster
Cultivation of stem cells extracted from amniotic fluid will help treat congenital conditions
Company is pushing for legislation that would limit its legal exposure over allegedly carcinogenic product
New Pasteur Institute head highlights risks posed by shortages of money, staff and political goodwill
GHO Capital has put contract research group FairJourney Biologics up for sale
Pharmaceutical companies scale back development in aftermath of pandemic
Research shows urgent need for policies to encourage weight loss and cut disease risk
Struggling German chemicals group announces boardroom reshuffle ahead of update on potential break-up
‘Brain fog’ detectable in long and short-term cases, detailed study suggests
Physicians complain of overwork and low pay as healthcare system faces looming demographic crisis
Spinning off consumer health is no easy fix but a sale would offer a quicker turnaround
Replacing a top researcher with a private sector manager would send entirely the wrong signal
International Edition